These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6753894)

  • 1. Long-term experience of captopril in the treatment of primary (essential) hypertension.
    Karlberg BE; Asplund J; Wettre S; Ohman KP; Nilsson OR
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):133S-137S. PubMed ID: 6753894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
    Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
    Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.
    Weinberger MH
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):127S-131S. PubMed ID: 6753893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril or atenolol in essential hypertension.
    Andrén L; Svensson A; Hansson L
    Acta Med Scand Suppl; 1983; 677():115-8. PubMed ID: 6367371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in essential hypertension.
    Rabinad Estrada E; Ingelmo Morin M; Martinez Amenos A; Alsina J; Balcells Gorina A
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):103S-105S. PubMed ID: 6753890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril and hydrochlorothiazide in the fixed combination multicenter trial.
    Lederle RM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S63-9. PubMed ID: 2580179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment.
    Vlasses PH; Rotmensch HH; Swanson BN; Mojaverian P; Ferguson RK
    Arch Intern Med; 1982 Jun; 142(6):1098-101. PubMed ID: 6284081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.
    Veterans Administration Co-Operative Study Group on Antihypertensive Agents
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):97S-101S. PubMed ID: 6753911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB; Atlas SA; Marion RM; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    Arch Intern Med; 1984 Oct; 144(10):1947-53. PubMed ID: 6237623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.
    Andrén L; Karlberg B; Ohman P; Svensson A; Asplund J; Hansson L
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):107S-111S. PubMed ID: 6753891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schreyer S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes.
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S70-6. PubMed ID: 2580180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.
    el-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    Br J Clin Pharmacol; 1981 May; 11(5):469-75. PubMed ID: 7023522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients.
    Holland OB; von Kuhnert L; Campbell WB; Anderson RJ
    Hypertension; 1983; 5(2):235-9. PubMed ID: 6337951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.